Topical JAK Inhibitor Oil-in-Water Emulsion With Stable Skin Permeation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for stable, easily applied topical formulations of JAK inhibitors with good skin permeation characteristics for the treatment of skin disorders.
Innovation Solution
A pharmaceutical formulation comprising an oil-in-water emulsion with a therapeutically effective amount of (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile or its pharmaceutically acceptable salt, which includes components like water, oil, emulsifier, occlusive agent, and solvent, designed for improved skin permeation and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a topical formulation of JAK inhibitor is developed, then skin permeation is enhanced, but formulation stability and appearance may be compromised
Solution Approach 1:
The patent employs parameter changes by adjusting the pH of the formulation to be within a specific range (pH 3-6) to optimize both skin permeation and formulation stability. The pH adjustment allows the JAK inhibitor to maintain appropriate ionization state for skin penetration while preventing degradation and maintaining emulsion stability throughout storage.
Solution Approach 2:
The formulation uses a composite oil-in-water emulsion system combining multiple components including emulsifiers, occlusive agents, and the JAK inhibitor in a stabilized matrix. This composite structure enables the formulation to achieve both good skin permeation properties and long-term stability by distributing the active ingredient within a protective emulsion framework.
2Ease of operation
If a topical formulation is designed for easy application, then spreadability is improved, but formulation complexity increases
Solution Approach 1:
The patent adjusts the viscosity and rheological parameters of the formulation to achieve optimal spreadability. By controlling the viscosity within a specific range and adjusting the emulsion droplet size distribution, the formulation becomes easily applicable and spreads well on skin without requiring complex application devices or procedures.
Solution Approach 2:
The formulation incorporates local quality variations through the emulsion structure, where different phases (oil and water) provide different functions in specific regions of the formulation. The emulsifier molecules orient themselves at the interface between oil and water phases, creating localized properties that enhance both spreadability and stability without increasing overall formulation complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The oil-in-water formulation demonstrates better appearance, spreadability, and stability, leading to enhanced skin permeation and consistent permeation profiles, making it suitable for effective topical treatment of skin disorders.
Implementation Method 1
A pharmaceutical formulation for topical skin application comprising an oil-in-water emulsion
Implementation Method 2
which includes components like water, oil, emulsifier, occlusive agent, and solvent, designed for improved skin permeation and stability
Data Source
AI summary
This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.